(SAN DIEGO)Acadia Pharmaceuticals Inc. said Tuesday it will cut its work force in half as it restructures to cut expenses and focus on a few late-stage drug candidates.READ MORE
(SAN DIEGO)Acadia Pharmaceuticals Inc. posted a larger second-quarter loss Tuesday as research costs increased and several drug development collaborations ended, slowing its revenue to a tric...READ MORE
(NEW YORK)Shares of Acadia Pharmaceuticals Inc. jumped Tuesday, after a Banc of America Securities analyst removed his "Sell" rating, citing the stock's rock-bottom valuation.READ MORE
Among the premarket stories for Tuesday, June 17, from AP Financial News: NEW YORK (AP)--Analysts turned their attention to Acadia Pharmaceuticals Inc.'s future and its drug ca...READ MORE
(NEW YORK)Analysts turned their attention to Acadia Pharmaceuticals Inc.'s future and its drug candidate pimavanserin Tuesday, a day after the company reported the failure of another sch...READ MORE
Among the stock activity stories for Monday, June 16, from AP Financial News: NEW YORK (AP)--Shares of Acadia Pharmaceuticals Inc. fell to an all-time low Monday after the biotechn...READ MORE